CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Zotec Partners

Zotec Partners is an industry leading provider of specialized medical billing and practice management services for the hospital-based specialty market. The company is committed to the continual pursuit of excellence in the physician revenue cycle management industry by delivering effective solutions through personalized service and measurable client results. Zotec Partners` proprietary processes and technology manage in excess of 70 million medical encounters across all 50 states.

MedPoint Digital

MedPoint is focused on innovative, high-value services. We are a global best-in-class company in our service areas. We work with clients on new approaches to training, education and communications that work in the real world of medicine.

Steele

Brooks Rand

Brooks Rand is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pacific Sleep Disorders Center

Pacific Sleep Disorders Center is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.